Scientific Opinion on the substantiation of health claims related to a combination of <em>Lactobacillus paracasei</em> CNCM I-1688 and <em>Lactobacillus salivarius</em> CNCM I-1794 and reduction of gastro-intestinal discomfort (ID 2972), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 2972), improved lactose digestion (ID 2972) and increasing IL-10 production (ID 2973) (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Scientific Opinion on the substantiation of health claims related to a combination of <em>Lactobacillus paracasei</em> CNCM I-1688 and <em>Lactobacillus salivarius</em> CNCM I-1794 and reduction of gastro-intestinal discomfort (ID 2972), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 2972), improved lactose digestion (ID 2972) and increasing IL-10 production (ID 2973) (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

<p>Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to provide a scientific opinion on health claims pursuant to Article 13 of Regulation (EC) No 1924/2006 in the framework of further assessment related to a combi...

Full description

Bibliographic Details
Main Author: EFSA Panel on Dietetic Products, Nutrition and Allergies
Format: Article
Language:English
Published: Wiley 2012-08-01
Series:EFSA Journal
Subjects:
Lactobacillus paracasei CNCM I-1688
Lactobacillus salivarius CNCM I-1794
gastro-intestinal discomfort
pathogens
lactose digestion
IL-10
health claims
Online Access:http://www.efsa.europa.eu/en/efsajournal/doc/2856.pdf

Internet

http://www.efsa.europa.eu/en/efsajournal/doc/2856.pdf

Similar Items